Richard J. Friedman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Richard J. Friedman has a total of 321 co-authors. Here are the top co-authors by number of shared publications:
- Josef K. Eichinger
Medical University of South Carolina Charleston South Carolina U.S.A.
81 shared publications - Brandon L. Rogalski
Medical University of South Carolina
44 shared publications Alexander S. Guareschi
29 shared publications- John W. Moore
Medical University of South Carolina, Charleston, SC, USA
27 shared publications - Christopher P. Roche
Exactech, Inc., Gainesville, FL, USA
15 shared publications Josef K. Eichinger
Department of Orthopaedics and Physical Medicine and Rehabilitation, Medical University of South Carolina
15 shared publications
Latest Publications
- 23 October 2026
- Published by Wolters Kluwer Health in Current Orthopaedic Practice
Demographic trends and Medicare reimbursement for rotator cuff repair 2013–2023
Introduction: Rates of rotator cuff repair (RCR) have increased over the past two decades, while reimbursement rates may not have increased to compensate for inflation. The purpose of this study was to examine the trends in reimbursement and provider demographics in RCR surgery for Medicare patients from 2013 to 2023. The null hypothesis is that there has been no significant change in reimbursement for physicians performing RCR surgery over the period. Methods: This retrospective cohort study used the Center for Medicare and Medicaid Services (CMS) “Physicians and Other Practitioners: By Provider and Service” database combined with the National Downloadable File. The database was queried from 2013 to 2023 to find surgeons performing RCR using CPT codes 29827, 23410, 23412, and 23420. Physicians were included if classified under “Orthopedic Surgery.” After exclusions, the cohort comprised 17,336 surgeons for CPT 29827, 245 for 23410, 1911 for 23412, and 325 for 23420. Data collected included demographics and reimbursement. Results: A total of 19,847 orthopedic surgeons performed RCR. The majority (87%) performed arthroscopic repair (CPT-29827), which accounted for 89% of total cases while generating the greatest reimbursement (adjusted AMSA $1,001; API $20,803). From 2013 to 2023, all CPT codes demonstrated declining reimbursement after inflation adjustment, with AMSA decreasing 24% for CPT-29827, 26% for CPT-23410, 24% for CPT-23412, and 38% for CPT-23420. Conclusions: Arthroscopic RCR is replacing open techniques, while reimbursement for all RCR procedures continues to fall significantly. These trends may impact financial sustainability and worsen disparities in access to care. Level of Evidence: Level IV—Descriptive Epidemiology/Economic Study
- 23 October 2026
- Published by Wolters Kluwer Health in Current Orthopaedic Practice
Demographic trends and Medicare reimbursement for rotator cuff repair 2013–2023
Introduction: Rates of rotator cuff repair (RCR) have increased over the past two decades, while reimbursement rates may not have increased to compensate for inflation. The purpose of this study was to examine the trends in reimbursement and provider demographics in RCR surgery for Medicare patients from 2013 to 2023. The null hypothesis is that there has been no significant change in reimbursement for physicians performing RCR surgery over the period. Methods: This retrospective cohort study used the Center for Medicare and Medicaid Services (CMS) “Physicians and Other Practitioners: By Provider and Service” database combined with the National Downloadable File. The database was queried from 2013 to 2023 to find surgeons performing RCR using CPT codes 29827, 23410, 23412, and 23420. Physicians were included if classified under “Orthopedic Surgery.” After exclusions, the cohort comprised 17,336 surgeons for CPT 29827, 245 for 23410, 1911 for 23412, and 325 for 23420. Data collected included demographics and reimbursement. Results: A total of 19,847 orthopedic surgeons performed RCR. The majority (87%) performed arthroscopic repair (CPT-29827), which accounted for 89% of total cases while generating the greatest reimbursement (adjusted AMSA $1,001; API $20,803). From 2013 to 2023, all CPT codes demonstrated declining reimbursement after inflation adjustment, with AMSA decreasing 24% for CPT-29827, 26% for CPT-23410, 24% for CPT-23412, and 38% for CPT-23420. Conclusions: Arthroscopic RCR is replacing open techniques, while reimbursement for all RCR procedures continues to fall significantly. These trends may impact financial sustainability and worsen disparities in access to care. Level of Evidence: Level IV—Descriptive Epidemiology/Economic Study
- 29 September 2026
- Published by SAGE Publications in Shoulder & Elbow
Infection risk following total shoulder arthroplasty in patients with diabetic foot ulcers
Introduction: Diabetic foot ulcers (DFU) reflect advanced diabetic microvascular and immunologic dysfunction and are associated with increased postoperative infection risk in lower-extremity arthroplasty. Their impact on total shoulder arthroplasty (TSA) outcomes, however, remains poorly defined. The purpose of this study is to determine the effect of DFU on periprosthetic joint infection (PJI), deep wound infection, and sepsis in diabetic patients undergoing primary TSA. Methods: Using the PearlDiver Mariner database from 2010 to 2023, diabetic patients undergoing primary TSA were identified and stratified by DFU status using ICD-10 codes. Primary outcomes were postoperative sepsis, deep infection, and PJI at 90 days and 1 year. Multivariable logistic regression assessed the association between DFU status and postoperative complications. Results: Among 56,482 diabetic patients undergoing TSA, 2404 had DFU (4.3%). Compared with diabetics without DFU, DFU patients had significantly higher rates of sepsis at 90 days (1.62% vs 0.86%) and 1 year (5.86% vs 2.30%), PJI at 1 year (1.70% vs 1.09%), and deep infection at 1 year (0.67% vs 0.28%) (all p < 0.01). DFU was independently associated with increased odds of PJI (OR 2.23; 95% CI 1.85–2.67), deep infection (OR 2.99; 95% CI 2.41–3.69), and sepsis (OR 3.93; 95% CI 3.61–4.29). Conclusion: The presence of DFU was independently associated with increased odds of sepsis, deep infection, and PJI following TSA. DFU may reflect a high-risk diabetic phenotype with impaired immunity and microvascular dysfunction. DFU status should be taken into account during preoperative informed consent and counseling, perioperative optimization, and postoperative surveillance. Level of Evidence: Level III—retrospective cohort study.
- 29 September 2026
- Published by SAGE Publications in Shoulder & Elbow
Infection risk following total shoulder arthroplasty in patients with diabetic foot ulcers
Introduction: Diabetic foot ulcers (DFU) reflect advanced diabetic microvascular and immunologic dysfunction and are associated with increased postoperative infection risk in lower-extremity arthroplasty. Their impact on total shoulder arthroplasty (TSA) outcomes, however, remains poorly defined. The purpose of this study is to determine the effect of DFU on periprosthetic joint infection (PJI), deep wound infection, and sepsis in diabetic patients undergoing primary TSA. Methods: Using the PearlDiver Mariner database from 2010 to 2023, diabetic patients undergoing primary TSA were identified and stratified by DFU status using ICD-10 codes. Primary outcomes were postoperative sepsis, deep infection, and PJI at 90 days and 1 year. Multivariable logistic regression assessed the association between DFU status and postoperative complications. Results: Among 56,482 diabetic patients undergoing TSA, 2404 had DFU (4.3%). Compared with diabetics without DFU, DFU patients had significantly higher rates of sepsis at 90 days (1.62% vs 0.86%) and 1 year (5.86% vs 2.30%), PJI at 1 year (1.70% vs 1.09%), and deep infection at 1 year (0.67% vs 0.28%) (all p < 0.01). DFU was independently associated with increased odds of PJI (OR 2.23; 95% CI 1.85–2.67), deep infection (OR 2.99; 95% CI 2.41–3.69), and sepsis (OR 3.93; 95% CI 3.61–4.29). Conclusion: The presence of DFU was independently associated with increased odds of sepsis, deep infection, and PJI following TSA. DFU may reflect a high-risk diabetic phenotype with impaired immunity and microvascular dysfunction. DFU status should be taken into account during preoperative informed consent and counseling, perioperative optimization, and postoperative surveillance. Level of Evidence: Level III—retrospective cohort study.
- Open Access
- 9 September 2026
- Published by Wiley in Arthroscopy, Sports Medicine, and Rehabilitation
- Vol. 8 (5)
Arthroscopic Capsular Plication Shows Low Failure Rates and Meaningful Functional Improvement in Multidirectional Shoulder Instability With and Without Hypermobile Ehlers‐Danlos Syndrome
Purpose: To evaluate clinical outcomes and failure rates after arthroscopic capsular plication for multidirectional shoulder instability in patients with and without hypermobile Ehlers‐Danlos syndrome. Methods: A retrospective case series with prospectively collected outcomes was conducted between 2015 and 2023 in patients undergoing arthroscopic capsular plication for multidirectional shoulder instability with and without hypermobile Ehlers‐Danlos syndrome, with a minimum of 2 years of follow‐up. Outcomes included American Shoulder and Elbow Surgeons, Single Assessment Numeric Evaluation, and Visual Analog Score pain scores. Failure was defined as recurrent instability or revision surgery. Results: Patients showed significant improvement in functional outcome scores and pain after surgery. Failure occurred in 6.7% of patients at a mean of 17 months postoperatively. Clinically meaningful improvement exceeding the minimal clinically important difference was achieved by 100% of patients for American Shoulder and Elbow Surgeons, 65.2% for Single Assessment Numeric Evaluation, and 64.5% for Visual Analog Score pain. Conclusions: Arthroscopic capsular plication was associated with meaningful functional improvement and a low failure rate in patients with multidirectional shoulder instability with and without hypermobile Ehlers‐Danlos syndrome. Level of Evidence: Level IV, therapeutic‐retrospective case series.
- 9 September 2026
- Published by Wiley in Arthroscopy, Sports Medicine, and Rehabilitation
- Vol. 8 (5)
Open AccessArthroscopic Capsular Plication Shows Low Failure Rates and Meaningful Functional Improvement in Multidirectional Shoulder Instability With and Without Hypermobile Ehlers‐Danlos Syndrome
Purpose: To evaluate clinical outcomes and failure rates after arthroscopic capsular plication for multidirectional shoulder instability in patients with and without hypermobile Ehlers‐Danlos syndrome. Methods: A retrospective case series with prospectively collected outcomes was conducted between 2015 and 2023 in patients undergoing arthroscopic capsular plication for multidirectional shoulder instability with and without hypermobile Ehlers‐Danlos syndrome, with a minimum of 2 years of follow‐up. Outcomes included American Shoulder and Elbow Surgeons, Single Assessment Numeric Evaluation, and Visual Analog Score pain scores. Failure was defined as recurrent instability or revision surgery. Results: Patients showed significant improvement in functional outcome scores and pain after surgery. Failure occurred in 6.7% of patients at a mean of 17 months postoperatively. Clinically meaningful improvement exceeding the minimal clinically important difference was achieved by 100% of patients for American Shoulder and Elbow Surgeons, 65.2% for Single Assessment Numeric Evaluation, and 64.5% for Visual Analog Score pain. Conclusions: Arthroscopic capsular plication was associated with meaningful functional improvement and a low failure rate in patients with multidirectional shoulder instability with and without hypermobile Ehlers‐Danlos syndrome. Level of Evidence: Level IV, therapeutic‐retrospective case series.
- 3 September 2026
- Published by SAGE Publications in Shoulder & Elbow
Perioperative proton pump inhibitors use and postoperative surgical complications following primary total shoulder arthroplasty
Background: Proton pump inhibitors (PPIs) are commonly used perioperatively, but their effect on postoperative total shoulder arthroplasty (TSA) outcomes is unclear. The purpose of this study is to determine the effects of perioperative PPIs on surgical complications following primary TSA. Methods: A retrospective cohort study using TriNetX identified patients undergoing TSA using CPT code 23472. The exposure cohort included patients prescribed a perioperative PPI from seven days preoperatively to two days postoperatively and underwent propensity score matching 1:1 to its nearest neighbor. Surgical outcomes were studied at 3 years. Risk ratios (RRs), 95% confidence intervals (CIs), and p -values were reported. Statistical significance was set at p < 0.05. Results: At 3 years postoperatively, PPI cohort had increased rates of aseptic loosening (1.3% vs. 0.7%; RR 1.9; 95% CI 1.0, 3.6; p = 0.034), dislocation (2.3% vs. 1.3%; RR 1.7; 95% CI 1.1, 2.7; p = 0.017), and revision TSA (3.0% vs. 2.0%; RR 1.5; 95% CI 1.0, 2.2; p = 0.031), and overall complications (5.7% vs. 4.3%; RR 1.3; 95% CI 1.0, 1.7; p = 0.043) compared to matched controls. Conclusion: Perioperative PPI use was associated with increased rates of aseptic loosening, dislocation, and revision TSA through 3 years following primary TSA, suggesting PPI exposure may be an important preoperative risk factor. Level of Evidence: Level III—Retrospective cohort study
- 3 September 2026
- Published by SAGE Publications in Shoulder & Elbow
Perioperative proton pump inhibitors use and postoperative surgical complications following primary total shoulder arthroplasty
Background: Proton pump inhibitors (PPIs) are commonly used perioperatively, but their effect on postoperative total shoulder arthroplasty (TSA) outcomes is unclear. The purpose of this study is to determine the effects of perioperative PPIs on surgical complications following primary TSA. Methods: A retrospective cohort study using TriNetX identified patients undergoing TSA using CPT code 23472. The exposure cohort included patients prescribed a perioperative PPI from seven days preoperatively to two days postoperatively and underwent propensity score matching 1:1 to its nearest neighbor. Surgical outcomes were studied at 3 years. Risk ratios (RRs), 95% confidence intervals (CIs), and p -values were reported. Statistical significance was set at p < 0.05. Results: At 3 years postoperatively, PPI cohort had increased rates of aseptic loosening (1.3% vs. 0.7%; RR 1.9; 95% CI 1.0, 3.6; p = 0.034), dislocation (2.3% vs. 1.3%; RR 1.7; 95% CI 1.1, 2.7; p = 0.017), and revision TSA (3.0% vs. 2.0%; RR 1.5; 95% CI 1.0, 2.2; p = 0.031), and overall complications (5.7% vs. 4.3%; RR 1.3; 95% CI 1.0, 1.7; p = 0.043) compared to matched controls. Conclusion: Perioperative PPI use was associated with increased rates of aseptic loosening, dislocation, and revision TSA through 3 years following primary TSA, suggesting PPI exposure may be an important preoperative risk factor. Level of Evidence: Level III—Retrospective cohort study
- 21 July 2026
- Published by SAGE Publications in Shoulder & Elbow
Hormone replacement therapy and complications after primary total shoulder arthroplasty
Background: Hormone replacement therapy (HRT) is commonly prescribed to alleviate symptoms of menopause. Incidence of women undergoing total shoulder arthroplasty (TSA) continues to rise, yet the impact of HRT on primary TSA outcomes remains unclear. The purpose of this study is to examine the effects of HRT on postoperative complications following primary TSA. Methods: The PearlDiver Mariner database was queried for menopausal aged females undergoing primary TSA between 2010 and 2023. Patients with prior history of breast cancer, deep vein thrombosis (DVT), pulmonary embolism, or stroke were excluded. Patients prescribed HRT within 365 days preoperatively were propensity score matched 1:1 to non-users. Chi-square analysis and multivariable logistic regression were used to evaluate associations between HRT use and postoperative complications. Statistical significance was defined as p < . 05. Results: HRT users had lower incidence of acute kidney injury (AKI) ( p = . 02) at 180 days and lower incidence of AKI ( p = . 03) and pneumonia ( p = . 04) at 365 days. HRT was found to be independently predictive of decreased rates of AKI ( p = . 03), UTI ( p = . 02), pneumonia ( p = . 01), and transfusion ( p = . 01) following TSA. Conclusion: HRT was found to be independently associated with reduced medical complications following primary TSA and was not associated with surgical complications following primary TSA. Level of evidence: Level III – Retrospective cohort study
- 21 July 2026
- Published by SAGE Publications in Shoulder & Elbow
Hormone replacement therapy and complications after primary total shoulder arthroplasty
Background: Hormone replacement therapy (HRT) is commonly prescribed to alleviate symptoms of menopause. Incidence of women undergoing total shoulder arthroplasty (TSA) continues to rise, yet the impact of HRT on primary TSA outcomes remains unclear. The purpose of this study is to examine the effects of HRT on postoperative complications following primary TSA. Methods: The PearlDiver Mariner database was queried for menopausal aged females undergoing primary TSA between 2010 and 2023. Patients with prior history of breast cancer, deep vein thrombosis (DVT), pulmonary embolism, or stroke were excluded. Patients prescribed HRT within 365 days preoperatively were propensity score matched 1:1 to non-users. Chi-square analysis and multivariable logistic regression were used to evaluate associations between HRT use and postoperative complications. Statistical significance was defined as p < . 05. Results: HRT users had lower incidence of acute kidney injury (AKI) ( p = . 02) at 180 days and lower incidence of AKI ( p = . 03) and pneumonia ( p = . 04) at 365 days. HRT was found to be independently predictive of decreased rates of AKI ( p = . 03), UTI ( p = . 02), pneumonia ( p = . 01), and transfusion ( p = . 01) following TSA. Conclusion: HRT was found to be independently associated with reduced medical complications following primary TSA and was not associated with surgical complications following primary TSA. Level of evidence: Level III – Retrospective cohort study
- 14 July 2026
- Published by SAGE Publications in Shoulder & Elbow
Selective serotonin reuptake inhibitors and complications following primary total shoulder arthroplasty
Background: Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed medications; however, they have been associated with increased bleeding risk. Total shoulder arthroplasty (TSA) literature remains lacking. The purpose of this study is to examine the effect of SSRI on postoperative hematologic and surgical complications following primary TSA. Methods: The PearlDiver Mariner database was queried for patients undergoing primary TSA. SSRI cohort consisted of patients prescribed an SSRI within 365 days preoperatively. Propensity score matching was performed to yield the non-SSRI cohort. Chi-square analysis assessed complication rates, and multivariable logistic regression determined whether SSRI use independently predicted complications. Significance was defined as p < 0.05. Results: Following chi-square analysis, SSRI cohort demonstrated higher rates of transfusion at 90 days (1.10% vs. 0.90%, p = 0.01) and 1 year (1.66% vs 1.44%, p = 0.04) postoperatively. SSRI cohort had higher rates of revision TSA (3.57% vs. 3.17%, p = 0.003) and mechanical failure (1.70% vs. 1.50%, p = 0.034) at 5 years postoperatively. After multivariable regression, SSRI cohort was not independently predictive of any postoperative complications. Conclusion: SSRI was not independently predicative of any postoperative hematological or surgical complications following primary TSA. Therefore, SSRI use in TSA appears to be safe to take preoperatively and does not increase complications. Level of evidence: Level III – Retrospective cohort study.
- 14 July 2026
- Published by SAGE Publications in Shoulder & Elbow
Selective serotonin reuptake inhibitors and complications following primary total shoulder arthroplasty
Background: Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed medications; however, they have been associated with increased bleeding risk. Total shoulder arthroplasty (TSA) literature remains lacking. The purpose of this study is to examine the effect of SSRI on postoperative hematologic and surgical complications following primary TSA. Methods: The PearlDiver Mariner database was queried for patients undergoing primary TSA. SSRI cohort consisted of patients prescribed an SSRI within 365 days preoperatively. Propensity score matching was performed to yield the non-SSRI cohort. Chi-square analysis assessed complication rates, and multivariable logistic regression determined whether SSRI use independently predicted complications. Significance was defined as p < 0.05. Results: Following chi-square analysis, SSRI cohort demonstrated higher rates of transfusion at 90 days (1.10% vs. 0.90%, p = 0.01) and 1 year (1.66% vs 1.44%, p = 0.04) postoperatively. SSRI cohort had higher rates of revision TSA (3.57% vs. 3.17%, p = 0.003) and mechanical failure (1.70% vs. 1.50%, p = 0.034) at 5 years postoperatively. After multivariable regression, SSRI cohort was not independently predictive of any postoperative complications. Conclusion: SSRI was not independently predicative of any postoperative hematological or surgical complications following primary TSA. Therefore, SSRI use in TSA appears to be safe to take preoperatively and does not increase complications. Level of evidence: Level III – Retrospective cohort study.
- Open Access
- 7 July 2026
- Published by SAGE Publications in Orthopaedic Journal of Sports Medicine
- Vol. 14 (7)
Are Suture Spanning Repair Techniques Replacing Traditional Tommy John Surgery? Prevalence and Complication Rates Following Ulnar Collateral Ligament Repair or Reconstruction
Background: Ulnar collateral ligament (UCL) reconstruction has historically been considered the gold standard treatment for severe UCL tears. With the advent of suture-spanning repair techniques, some studies suggest that UCL repair is being performed with increasing frequency. This study provides a large analysis of UCL reconstruction versus repair trends in the United States following the introduction of suture-spanning repair techniques. Purpose: To compare the prevalence and complication rates of UCL reconstruction versus repair over a 5-year span following the introduction of suture spanning repair techniques. We also sought to determine if there was an age-related preference for reconstruction versus repair and whether the addition of an ulnar nerve transposition (UNT) affected short-term complication rates. Study Design: Cohort study; Level of evidence, 3. Methods: Using the Merative MarketScan research databases, which contain deidentified patient national claims information, we retrospectively identified patients aged 14 to 30 years who underwent UCL reconstruction or repair between 2016 and 2021, with or without UNT. Patients with a fracture diagnosis at the time of surgery were excluded. Demographic information including age, sex, and geographic region was collected. The number of patients who experienced infection, ulnar neuropathy, device-related complications, and unspecified complications were obtained for each procedure. Results: A total of 1191 reconstruction patients and 696 repair patients were identified. 36.8% of patients who underwent either reconstruction or repair had a concomitant UNT. UCL reconstruction patients were approximately 3 years older than repair patients on average ( P < .001). Male patients accounted for 89.5% of reconstruction patients and 77.7% of repair patients. From 2016 to 2021, the number of reconstructions declined 32.0% and the number of repairs increased 81.6%. There were no differences in the rate of infection ( P = .36) and ulnar neuropathy ( P = .73) between reconstruction and repair. The overall risk of developing any complication was higher for repair patients (1.58%) than reconstruction patients (0.67%); however, this difference was not significant ( P = .09). Conclusion: Between 2016 and 2021, following the introduction of suture spanning UCL repair techniques, the number of UCL repairs increased and the number of reconstructions decreased. There was no difference in complication rates between UCL repair and UCL reconstruction and the rate of complication for either surgery remains low.
- 7 July 2026
- Published by SAGE Publications in Orthopaedic Journal of Sports Medicine
- Vol. 14 (7)
Open AccessAre Suture Spanning Repair Techniques Replacing Traditional Tommy John Surgery? Prevalence and Complication Rates Following Ulnar Collateral Ligament Repair or Reconstruction
Background: Ulnar collateral ligament (UCL) reconstruction has historically been considered the gold standard treatment for severe UCL tears. With the advent of suture-spanning repair techniques, some studies suggest that UCL repair is being performed with increasing frequency. This study provides a large analysis of UCL reconstruction versus repair trends in the United States following the introduction of suture-spanning repair techniques. Purpose: To compare the prevalence and complication rates of UCL reconstruction versus repair over a 5-year span following the introduction of suture spanning repair techniques. We also sought to determine if there was an age-related preference for reconstruction versus repair and whether the addition of an ulnar nerve transposition (UNT) affected short-term complication rates. Study Design: Cohort study; Level of evidence, 3. Methods: Using the Merative MarketScan research databases, which contain deidentified patient national claims information, we retrospectively identified patients aged 14 to 30 years who underwent UCL reconstruction or repair between 2016 and 2021, with or without UNT. Patients with a fracture diagnosis at the time of surgery were excluded. Demographic information including age, sex, and geographic region was collected. The number of patients who experienced infection, ulnar neuropathy, device-related complications, and unspecified complications were obtained for each procedure. Results: A total of 1191 reconstruction patients and 696 repair patients were identified. 36.8% of patients who underwent either reconstruction or repair had a concomitant UNT. UCL reconstruction patients were approximately 3 years older than repair patients on average ( P < .001). Male patients accounted for 89.5% of reconstruction patients and 77.7% of repair patients. From 2016 to 2021, the number of reconstructions declined 32.0% and the number of repairs increased 81.6%. There were no differences in the rate of infection ( P = .36) and ulnar neuropathy ( P = .73) between reconstruction and repair. The overall risk of developing any complication was higher for repair patients (1.58%) than reconstruction patients (0.67%); however, this difference was not significant ( P = .09). Conclusion: Between 2016 and 2021, following the introduction of suture spanning UCL repair techniques, the number of UCL repairs increased and the number of reconstructions decreased. There was no difference in complication rates between UCL repair and UCL reconstruction and the rate of complication for either surgery remains low.
- Open Access
- 12 May 2026
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 35 (11) , 2735-2745
Surgical options for the management of severe glenoid structural deficiencies in the setting of revision reverse shoulder arthroplasty: a systematic review
- 12 May 2026
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 35 (11) , 2735-2745
Open AccessSurgical options for the management of severe glenoid structural deficiencies in the setting of revision reverse shoulder arthroplasty: a systematic review
- 20 March 2026
- Published by SAGE Publications in Shoulder & Elbow
Outcomes of primary rotator cuff repair in non-diabetic patients using glucagon-like peptide-1 (GLP-1) receptor agonists: A propensity-matched analysis
Introduction: Use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has surged among non-diabetic individuals in response to the obesity epidemic. Their influence on musculoskeletal healing and orthopedic surgical outcomes remains poorly characterized. The purpose of this study is to evaluate postoperative outcomes following primary rotator cuff repair (RCR) in non-diabetic patients treated with GLP-1 RA. Methods: A retrospective cohort study was conducted using the TriNetX database to identify non-diabetic patients who underwent RCR. Patients prescribed GLP-1 RA were propensity score-matched 1:1 with non-users based on demographics and comorbidities. Surgical and medical outcomes were compared using risk ratios (RRs) with 95% confidence intervals. Results: GLP-1 RA use was associated with significantly lower rates of re-tear (RR = 0.699, p < 0.001) and occupational therapy utilization (RR = 0.686, p < 0.011). There were no significant differences in readmission rates, emergency department utilization, or mortality between groups. However, GLP-1 RA users had higher rates of cardiovascular complications (RR = 1.426, p = 0.038). Conclusion: GLP-1 RA use was associated with reduced rates of re-tear and occupational therapy utilization. No differences were observed in readmission rates, emergency department utilization, or mortality. These findings suggest a potential benefit of GLP-1 RA in musculoskeletal healing, though further investigation is needed to understand the mechanisms involved.
- 20 March 2026
- Published by SAGE Publications in Shoulder & Elbow
Outcomes of primary rotator cuff repair in non-diabetic patients using glucagon-like peptide-1 (GLP-1) receptor agonists: A propensity-matched analysis
Introduction: Use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has surged among non-diabetic individuals in response to the obesity epidemic. Their influence on musculoskeletal healing and orthopedic surgical outcomes remains poorly characterized. The purpose of this study is to evaluate postoperative outcomes following primary rotator cuff repair (RCR) in non-diabetic patients treated with GLP-1 RA. Methods: A retrospective cohort study was conducted using the TriNetX database to identify non-diabetic patients who underwent RCR. Patients prescribed GLP-1 RA were propensity score-matched 1:1 with non-users based on demographics and comorbidities. Surgical and medical outcomes were compared using risk ratios (RRs) with 95% confidence intervals. Results: GLP-1 RA use was associated with significantly lower rates of re-tear (RR = 0.699, p < 0.001) and occupational therapy utilization (RR = 0.686, p < 0.011). There were no significant differences in readmission rates, emergency department utilization, or mortality between groups. However, GLP-1 RA users had higher rates of cardiovascular complications (RR = 1.426, p = 0.038). Conclusion: GLP-1 RA use was associated with reduced rates of re-tear and occupational therapy utilization. No differences were observed in readmission rates, emergency department utilization, or mortality. These findings suggest a potential benefit of GLP-1 RA in musculoskeletal healing, though further investigation is needed to understand the mechanisms involved.
- Open Access
- 20 March 2026
- Published by Elsevier in Journal of Shoulder and Elbow Arthroplasty
- Vol. 10 (1-2) , 100014
The effect of Area Deprivation Index on clinical outcomes after total shoulder arthroplasty
- 20 March 2026
- Published by Elsevier in Journal of Shoulder and Elbow Arthroplasty
- Vol. 10 (1-2) , 100014
Open AccessThe effect of Area Deprivation Index on clinical outcomes after total shoulder arthroplasty